Auditors counted 33 basic indicators and 15 excellence indicators at the Unidad de Psoriasis of the Complejo Hospitalario Universitario de Toledo. That put the unit above the threshold for the highest Cuderma level, known as Excelente, which requires at least 28 basic indicators and 12 excellence indicators.
The Academia Española de Dermatología y Venereología, or AEDV, grants the certification. It recognises care that combines treatment with patient education and gives patients a role in health decisions.
The Cuderma programme assesses 53 quality criteria covering resources, clinical procedures and patient outcomes. Auditors visit the site, review medical records and examine diagnosis, treatment and follow-up. They also check available resources and staffing.
The 53 criteria fall into three groups: eight cover structure and human resources, 38 assess clinical processes, including diagnosis, treatment and monitoring, and the final seven measure healthcare outcomes.
Cristina Pérez, director general of Asistencia Sanitaria, led the award ceremony. Vanesa Aguilar, deputy managing director of the hospital, also attended, along with Blas Gómez, head of Dermatology; Pablo de la Cueva, secretary general of the AEDV; Antonio Manfredi, president of Acción Psoriasis; and Rita Bau, director of Institutional Relations at AbbVie. The Junta reported the event in an official note.
Psoriasis is a chronic inflammatory disease that can affect more than the skin. Elena Martínez, the dermatologist responsible for the service, pointed to possible cardiovascular and metabolic comorbidities. She also cited psoriatic arthritis in a impressive proportion of patients.
Since 2019, the unit has provided specialised, individualised care for people with moderate-to-severe or complex forms of the disease. Doctors tailor treatment to each patient’s characteristics and needs, then keep patients under close review.
A specialised nursing consultation supports that work. Nurses educate patients and help them adhere to treatment. The dermatology team also works with Rheumatology to look for early signs of psoriatic arthritis and arrange joint assessments when needed.
The structure is designed to address the disease as a whole, beyond visible skin lesions.
Psoriasis treatment has also changed as researchers have learned more about the immune mechanisms behind the disease. The stated aim is broader control, with fewer complications and a better quality of life.
That patient-centred focus contrasts with the housing pressures described in an earlier breakdown. The practical principle is similar: measure outcomes instead of relying on broad claims.
For patients in Toledo, the certification does not announce a new medicine or rule. Its practical significance is that the unit has met a demanding set of standards across the full care pathway.
Dermatology and nursing support, alongside cooperation with Rheumatology, give the service a more structured approach. The assessment also shows how the unit follows patients over time. It documents a review of chronic disease care and carries significance beyond prestige.
